111.94
price down icon0.01%   -0.01
 
loading
前日終値:
$111.95
開ける:
$112.88
24時間の取引高:
4.43M
Relative Volume:
1.06
時価総額:
$498.76B
収益:
$37.42B
当期純損益:
$13.05B
株価収益率:
46.49
EPS:
2.4077
ネットキャッシュフロー:
$9.51B
1週間 パフォーマンス:
-1.27%
1か月 パフォーマンス:
-5.14%
6か月 パフォーマンス:
-13.37%
1年 パフォーマンス:
+14.60%
1日の値動き範囲:
Value
$111.79
$113.02
1週間の範囲:
Value
$107.24
$113.76
52週間の値動き範囲:
Value
$94.73
$148.15

Novo Nordisk Adr Stock (NVO) Company Profile

Name
名前
Novo Nordisk Adr
Name
セクター
Healthcare (1179)
Name
電話
-
Name
住所
-
Name
職員
69,260
Name
Twitter
@novonordisk
Name
次回の収益日
2024-11-06
Name
最新のSEC提出書
Name
NVO's Discussions on Twitter

Novo Nordisk Adr Stock (NVO) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-05-30 開始されました Goldman Buy
2024-04-12 開始されました BMO Capital Markets Outperform
2024-01-23 開始されました Morgan Stanley Overweight
2024-01-16 再開されました UBS Neutral
2023-12-01 開始されました Cantor Fitzgerald Overweight
2023-10-02 開始されました Argus Buy
2023-07-14 開始されました HSBC Securities Buy
2022-07-15 アップグレード Morgan Stanley Equal-Weight → Overweight
2022-06-28 ダウングレード UBS Neutral → Sell
2022-06-27 アップグレード Exane BNP Paribas Underperform → Neutral
2022-06-07 アップグレード JP Morgan Neutral → Overweight
2022-05-31 アップグレード Guggenheim Neutral → Buy
2022-04-25 アップグレード Cowen Market Perform → Outperform
2022-04-12 アップグレード Morgan Stanley Underweight → Equal-Weight
2022-03-16 アップグレード Deutsche Bank Hold → Buy
2022-01-25 ダウングレード Liberum Hold → Sell
2021-12-20 ダウングレード JP Morgan Overweight → Neutral
2021-12-17 ダウングレード Deutsche Bank Buy → Hold
2021-01-20 ダウングレード Credit Suisse Outperform → Neutral
2021-01-15 開始されました Deutsche Bank Buy
2020-09-29 開始されました Berenberg Hold
2020-07-06 ダウングレード BofA Securities Buy → Neutral
2020-05-11 ダウングレード UBS Buy → Neutral
2020-05-04 開始されました Cowen Market Perform
2020-03-16 アップグレード BofA/Merrill Neutral → Buy
2020-01-03 ダウングレード Guggenheim Buy → Neutral
2019-11-18 アップグレード Barclays Equal Weight → Overweight
2019-09-17 アップグレード Citigroup Neutral → Buy
2019-08-30 ダウングレード Jefferies Hold → Underperform
2019-06-20 ダウングレード Deutsche Bank Buy → Hold
2019-06-11 アップグレード Barclays Underweight → Equal Weight
2019-04-29 アップグレード Credit Suisse Neutral → Outperform
2019-01-29 開始されました Exane BNP Paribas Outperform
2018-12-11 再開されました Jefferies Hold
2018-10-09 開始されました Guggenheim Buy
2017-12-29 アップグレード JP Morgan Underweight → Neutral
2017-12-06 アップグレード BofA/Merrill Neutral → Buy
2017-12-01 アップグレード Morgan Stanley Equal-Weight → Overweight
2017-09-25 ダウングレード Exane BNP Paribas Outperform → Neutral
2017-09-06 アップグレード BofA/Merrill Underperform → Neutral
すべてを表示

Novo Nordisk Adr (NVO) 最新ニュース

pulisher
Oct 31, 2024

Why Is Regeneron Pharmaceuticals Stock Trading Lower Today? - Benzinga

Oct 31, 2024
pulisher
Oct 23, 2024

Novo Nordisk A/S (NVO) Stock Price, News, Quote & History - Yahoo Finance

Oct 23, 2024
pulisher
Oct 21, 2024

European Equities Traded in the US as American Depositary Receipts Open Week Slightly Higher - MSN

Oct 21, 2024
pulisher
Oct 18, 2024

Why this money manager sees FirstService, Novo Nordisk and Microsoft as good long-term holdings - The Globe and Mail

Oct 18, 2024
pulisher
Oct 16, 2024

NVO: 3 European Stocks to Buy as the Region Recovers - StockNews.com

Oct 16, 2024
pulisher
Oct 11, 2024

NVO’s price-to-cash ratio: How it affects the stock’s valuation. - US Post News

Oct 11, 2024
pulisher
Oct 09, 2024

Market cap of Novo Nordisk ADR [NVO] reaches 391.26B – now what? - The DBT News

Oct 09, 2024
pulisher
Oct 09, 2024

Analyzing Novo Nordisk ADR (NVO) After Recent Trading Activity - Knox Daily

Oct 09, 2024
pulisher
Oct 09, 2024

Monitoring Melco Resorts & Entertainment Ltd ADR (MLCO) after recent insider movements - Knox Daily

Oct 09, 2024
pulisher
Oct 07, 2024

Weekly Upgrades and Downgrades - InvestorPlace

Oct 07, 2024
pulisher
Oct 07, 2024

Precidian to List First ADRhedged Securities in the U.S. on Cboe - Traders Magazine

Oct 07, 2024
pulisher
Oct 03, 2024

Novo Nordisk Currently Down Six Consecutive Days, on Pace for Longest Losing Streak Since September 2022 — Data Talk - Morningstar

Oct 03, 2024
pulisher
Oct 02, 2024

Novo Nordisk ADR (NVO) receives a Buy rating from Goldman - Knox Daily

Oct 02, 2024
pulisher
Oct 02, 2024

The Attractiveness of Investing In Tenaris S.A. ADR (TS) is Growing - Knox Daily

Oct 02, 2024
pulisher
Oct 02, 2024

Stock Market Recap: Novo Nordisk ADR (NVO) Concludes at 118.01, a -0.89 Surge/Decline - The Dwinnex

Oct 02, 2024
pulisher
Oct 02, 2024

Banco Santander S.A. ADR [SAN] Investment Appeal on the Rise - Knox Daily

Oct 02, 2024
pulisher
Oct 02, 2024

Analyzing Indonesia Energy Corp Ltd (INDO) After Recent Trading Activity - Knox Daily

Oct 02, 2024
pulisher
Oct 02, 2024

CNH Industrial NV [CNH] Investment Guide: What You Need to Know - Knox Daily

Oct 02, 2024
pulisher
Oct 02, 2024

Company’s Banking Stock: Dissecting a -17.46% Quarterly Revenue Decline Amid Growth - The InvestChronicle

Oct 02, 2024
pulisher
Sep 27, 2024

Novo Nordisk ADR (NVO) Stock: A Year of Decreases and Increases - The InvestChronicle

Sep 27, 2024
pulisher
Sep 27, 2024

Novo Nordisk Slips On Analyst Warning Of Weaker Wegovy Sales - Investor's Business Daily

Sep 27, 2024
pulisher
Sep 26, 2024

Obesity Drugs: Can New Firms Take Market Share From Eli Lilly and Novo Nordisk? - Morningstar

Sep 26, 2024
pulisher
Sep 25, 2024

Eli Lilly Stock: Is LLY Stock A Buy After Snagging Approval For A New Eczema Drug? - Investor's Business Daily

Sep 25, 2024
pulisher
Sep 25, 2024

Analysts review Novo Nordisk ADR’s rating - Knox Daily

Sep 25, 2024
pulisher
Sep 24, 2024

Wall Street Analyst Initiated Novo Nordisk ADR [NVO]. What else is Wall St. saying - The DBT News

Sep 24, 2024
pulisher
Sep 24, 2024

Novo Nordisk A/S ADR (NVO-N) QuotePress Release - The Globe and Mail

Sep 24, 2024
pulisher
Sep 24, 2024

Balance Sheet Insights: Novo Nordisk ADR (NVO)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex

Sep 24, 2024
pulisher
Sep 23, 2024

Novo Nordisk ADR (NVO) Stock: A Year of Highs and Lows in the Market - The InvestChronicle

Sep 23, 2024
pulisher
Sep 21, 2024

European Equities Traded in the US as American Depositary Receipts Decrease Friday - MSN

Sep 21, 2024
pulisher
Sep 20, 2024

Novo Dives — And Corbus Crashes — On Psychiatric Side Effects Of Weight-Loss Drug - Investor's Business Daily

Sep 20, 2024

Novo Nordisk Adr (NVO) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$203.55
price down icon 0.16%
drug_manufacturers_general JNJ
$160.13
price up icon 0.17%
drug_manufacturers_general MRK
$101.88
price down icon 0.43%
drug_manufacturers_general NVS
$109.35
price up icon 0.88%
drug_manufacturers_general LLY
$818.93
price down icon 1.30%
大文字化:     |  ボリューム (24 時間):